1 minute reading time (102 words)

The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome

Source: Mayo Clinic Proceedings
Abstract: Restless legs syndrome (RLS) is a distinct disorder, differing from chronic pain in many ways. Refractory RLS is characterized by unresponsiveness to dopamine agonists or alpha-2-delta ligands due to inadequate efficacy, augmentation, or adverse effects. This may result in severely impaired quality of life, profound insomnia, and suicidal depression. Opioid therapy is a mainstay in the management of these patients. This article summarizes the basic science and clinical evidence in support of their use, including the positive result of a large controlled multicenter study of 306 subjects, and outlines an approach to their use in clinical practice.
Read more...

Related Posts

The AAPM Annual Meeting offers education and networking opportunities for all members of the pain care team.

Learn More